Allspring Global Investments
FLNA

Allspring Global Investments’s Filana Therapeutics FLNA Stock Holding History

Allspring Global Investments’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,633
Closed -$77.1K – 2669
2023
Q3 		$77.1K Buy
4,633
+1,979
+75% +$39.2K ﹤0.01% 2101
2023
Q2 		$65.1K Buy
2,654
+1,748
+193% +$42.1K ﹤0.01% 2211
2023
Q1 		$21.9K Buy
906
+305
+51% +$8.45K ﹤0.01% 2485
2022
Q4 		$17.8K Sell
601
-14
-2% -$503 ﹤0.01% 2614
2022
Q3 		$25K Buy
+615
New +$16.6K ﹤0.01% 2572

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Allspring Global Investments's FLNA Position: Q4 2023 in Review

Allspring Global Investments sold out of Filana Therapeutics (FLNA) in Q4 2023, closing a stake of 4,633 shares — an estimated $77.1K sold.

Allspring Global Investments first reported a position in FLNA in Q3 2022 and held it in 5 quarters. The position peaked at $77.1K in Q3 2023. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2023.

  • Allspring Global Investments reported no remaining Filana Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 4,633 Filana Therapeutics shares in Q4 2023, an estimated $77.1K.
  • Allspring Global Investments first reported a position in Filana Therapeutics in Q3 2022 and held it in 5 quarters.
  • Allspring Global Investments's Filana Therapeutics position peaked at $77.1K in Q3 2023.
  • 153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.